TREATMENT FAILURE
Clinical trials for TREATMENT FAILURE explained in plain language.
Never miss a new study
Get alerted when new TREATMENT FAILURE trials appear
Sign up with your email to follow new studies for TREATMENT FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer patients with limited options: regorafenib trial launches
Disease control Not yet recruitingThis study tests the drug regorafenib in people with advanced liver cancer (HCC) and moderate liver problems (Child-Pugh B) whose cancer worsened after first-line immunotherapy. About 20 participants will take regorafenib pills daily for 3 weeks on, 1 week off. The goal is to see…
Matched conditions: TREATMENT FAILURE
Phase: PHASE2 • Sponsor: Ju Hyun Shim • Aim: Disease control
Last updated Jun 07, 2026 10:44 UTC
-
Second-line hope: new drug tested for liver cancer after initial failure
Disease control Not yet recruitingThis study tests a drug called regorafenib in about 24 adults with advanced liver cancer that got worse after treatment with lenvatinib. The goal is to see if regorafenib can slow tumor growth and be safe. Participants will take regorafenib pills and have regular scans to check t…
Matched conditions: TREATMENT FAILURE
Phase: PHASE2 • Sponsor: Ju Hyun Shim • Aim: Disease control
Last updated May 27, 2026 12:03 UTC